NCT00841594View on ClinicalTrials.gov

MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Raynaud's Phenomenon
Interventions
DRUG

nitroglycerin 0.9 % (MXQ-503)

MQX-503, topical cream for nitroglycerin 0.9% vs Nitroglycerin ointment 2%, USP.

DRUG

Nitroglycerin ointment 2%, USP

MQX-503, topical cream for nitroglycerin 0.9% vs Nitroglycerin ointment 2%, USP.

Trial Locations (1)

98418

Charles River Clinical Services, Tacoma

Sponsors
All Listed Sponsors
lead

MediQuest Therapeutics

INDUSTRY